Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA ‐Reporter Assay
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Koji Suzuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Receptors, IgG, Autoantibodies, Autoimmune Diseases, Antigen-Antibody Complex. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research, Keio University Academic Development Funds, Kowa Company.
Abstract (Originalsprache)
Objective
Immune complexes (ICs), formed by autoantigen and autoantibody, play a pathogenic role in systemic autoimmune diseases through stimulation of Fcγ receptors (FcγR). However, studies investigating bioactivity of circulating ICs across various diseases remain limited. We aimed to quantify bioactivity of serum ICs using an FcγR‐reporter cell assay and examine their association with disease activity.
Methods
We assessed the bioactivity of serum ICs using the FcγRIIIA‐reporter assay. Serum samples were obtained from healthy controls (n = 56), infectious disease controls (n = 12), systemic lupus erythematosus (SLE) (n = 175), Sjögren disease (n = 71), mixed connective tissue disease (n = 22), idiopathic inflammatory myopathies (n = 73), systemic sclerosis (n = 107), and rheumatoid arthritis (n = 51).
Results
The bioactivity of ICs was significantly elevated across various systemic autoimmune diseases and associated with disease activity. In SLE, bioactivity of ICs was notably elevated compared with other diseases. The bioactivity in patients with SLE reflected disease activity with sensitivity of 81% and specificity of 69%. In patients with low anti–double‐stranded DNA antibody levels, those with high IC bioactivity were at higher risk of clinical symptoms including nephritis, arthritis, and skin involvement, providing additive value in assessing SLE activity. Longitudinal analysis also showed that the FcγRIIIA‐reporter assay more sensitively reflected flares than conventional serological markers, and those who achieved a low FcγRIIIA‐reporter response within the initial 3 months tended to achieve remission at 24 months (90% vs 75%, P = 0.56).
Conclusions
The FcγRIIIA‐reporter assay enables precise quantification of pathogenic bioactivity of ICs in various systemic autoimmune diseases, providing complementary information to existing serological markers. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Koji Suzuki, Masaru Takeshita, Kotaro Matsumoto, Jun Kikuchi, Yuko Kaneko
Förderung
- Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research
- Keio University Academic Development Funds
- Kowa Company
- Program for the Advancement of Next Generation Research Projects, Japan Society for the Promotion of Science (JSPS) KAKENHI
- Keio University Ushioda Memorial Doctoral Student Grant
- Japan Society for the Promotion of Science
Zitieren
APA
Suzuki, K., Takeshita, M., Imai, Y., Fukui, H., Furuhashi, K., Matsumoto, K., Kikuchi, J., Yoshimoto, K., & Kaneko, Y. (2026). Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA ‐Reporter Assay. Arthritis & Rheumatology. https://doi.org/10.1002/art.70159
Vancouver
Suzuki K, Takeshita M, Imai Y, Fukui H, Furuhashi K, Matsumoto K, et al. Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA ‐Reporter Assay. Arthritis & Rheumatology. 2026. doi:10.1002/art.70159
BibTeX
@article{Suzuki2026,
author = {Suzuki, Koji and Takeshita, Masaru and Imai, Yuki and Fukui, Hiroyuki and Furuhashi, Kazunori and Matsumoto, Kotaro and Kikuchi, Jun and Yoshimoto, Keiko and Kaneko, Yuko},
title = {Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA ‐Reporter Assay},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70159}
}
EUVIMED